Kiniksa Pharmaceuticals International (KNSA) Other Working Capital Changes (2017 - 2026)

Kiniksa Pharmaceuticals International has reported Other Working Capital Changes for 10 years, with the latest figure at -$993000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Working Capital Changes fell 16.55% year-over-year to -$993000.0; the trailing twelve-month figure through Mar 2026 stood at $22.3 million (up 19.69% YoY), and the FY2025 full-year result was $22.5 million, up 14.99% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at -$993000.0, down from $9.8 million in the prior quarter.
• The five-year high for Other Working Capital Changes was $17.0 million in Q3 2024, with the low at -$4.7 million in Q2 2023.
• Historically, Other Working Capital Changes has averaged $2.5 million across 5 years, with a median of $33000.0 in 2024.
• The largest YoY upside for Other Working Capital Changes was 665700.0% in 2023 against a maximum downside of 42927.27% in 2023.
• Kiniksa Pharmaceuticals International's Other Working Capital Changes stood at $19000.0 in 2022, then jumped by 13447.37% to $2.6 million in 2023, then gained by 18.14% to $3.0 million in 2024, then soared by 221.57% to $9.8 million in 2025, then plunged by 110.15% to -$993000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$993000.0 (Q1 2026), $9.8 million (Q4 2025), and $507000.0 (Q3 2025), per Business Quant data.